Trials / Unknown
UnknownNCT04118933
A Study for PD-1 Antibody JS001 in MSI-H Advanced or Recurrent Colorectal Cancer
An Exploratory Study for PD-1 Antibody JS001 in Participants With Microsatellite Instability-high (MSI-H) Advanced or Recurrent Colorectal Cancer
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- Xu jianmin · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
To observe the efficacy of PD-1 antibody JS001 in the treatment of participants with microsatellite instability-high (MSI-H) advanced or recurrent colorectal cancer, so as to provide sufficient evidence for MSI-H as a biomarker of PD-1/PD-L1 inhibitor.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | JS001 | JS001 240mg, Q3W |
Timeline
- Start date
- 2019-07-17
- Primary completion
- 2020-07-17
- Completion
- 2021-07-17
- First posted
- 2019-10-08
- Last updated
- 2019-10-08
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04118933. Inclusion in this directory is not an endorsement.